Terminalia phanerophlebia
Terminalia phanerophlebia · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Terminalia phanerophlebia is a botanical species recognized for its significant therapeutic potential in traditional medicine. Research indicates that the plant possesses notable antimicrobial activities that can combat various pathogens. When prepared as a concentrated extract, its bioactive compounds become more accessible for medicinal use. This preparation is particularly studied for its efficacy in managing various respiratory diseases. Consequently, understanding its chemical profile is essential for developing new treatments for pulmonary ailments.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Combretaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Terminalia phanerophlebia is a distinctive tree known by a wide variety of regional and common names. It is frequently referred to as the Lebombo Cluster-leaf or simply the Lebombo Clusterleaf in many botanical circles. Some enthusiasts also identify the species as the Lebombo Terminalia to highlight its genus. In specific local contexts, it is recognized by the name Mambonjwane. Additionally, the tree is known as amaNgwamhlophe, reflecting the diverse linguistic heritage associated with its identity.
Sources: Catalogue of Life (COL)
Taxonomy
Terminalia phanerophlebia is a unique biological entity belonging to the kingdom Plantae. Within this vast kingdom, the species is classified under the class Equisetopsida. It further resides within the order Myrtales, showcasing its specific evolutionary lineage. As a member of the family Combretaceae, it shares structural characteristics with many related woody plants. Ultimately, its taxonomic identity is defined by its placement within the genus Terminalia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Combretaceae |
| Genus | Terminalia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Terminalia phanerophlebia is a notable species with a significant presence across the African continent. Its distribution is particularly concentrated within the regions of Southern Africa, where it thrives in diverse environments. In Mozambique, the plant establishes itself as part of the local tropical landscape. Furthermore, its range extends into Eswatini and through the varied terrains of South Africa, including KwaZulu-Natal and the Northern Provinces. This widespread occurrence highlights the species' adaptability to the different climates found throughout these southern territories.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Terminalia phanerophlebia is a self-supporting plant characterized by its distinct tree growth form. This species typically reaches a maximum height of 10 meters as it matures in its natural habitat. However, its stature can be much more modest, with a minimum height of only 1 meter. These varying dimensions allow the tree to adapt effectively to its environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Terminalia phanerophlebia has demonstrated significant antimicrobial activity in recent scientific evaluations. This finding stems from a study investigating South African medicinal plants traditionally used to treat tuberculosis and other respiratory ailments. Researchers tested various extracts from selected species against pathogens such as Klebsiella pneumoniae and Staphylococcus aureus. Among the results, the antimicrobial properties of this specific plant were found to authenticate its traditional role in managing respiratory infections. These promising results suggest that further phytochemical and pharmacological analyses are necessary to fully understand its therapeutic potential.
Compounds
Conditions
Terminalia phanerophlebia serves as a potent medicinal resource due to its ability to treat various respiratory diseases. Research validates its traditional use by demonstrating significant antimicrobial properties against microorganisms associated with respiratory infections. Additionally, this plant species exhibits remarkable quorum sensing inhibition by effectively treating violacein production (IVP). Specifically, extracts and fractions of the plant showed high potency in dose-dependent inhibition of IVP in Chromobacterium violaceum. These dual capabilities highlight its potential as both a treatment for respiratory ailments and a strategic agent against bacterial virulence.
Preparations
Terminalia phanerophlebia is prepared as an extract to investigate its potential for quorum sensing inhibition. This specific extract was identified as the most active species during in vitro screening against Chromobacterium violaceum. Researchers utilized the prepared extract and five of its corresponding fractions to demonstrate potent inhibition of violacein production. Through chemometric analysis of the extract, chemical markers such as olivetol and hydroxytyrosol were positively associated with its biological activity. These findings highlight the effectiveness of the Terminalia phanerophlebia extract as a candidate for combating antimicrobial resistance.